Eli Lilly-Incyte's Rheumatoid Arthritis Drug Gets OK From FDA For Solo Use In Hospitalized COVID-19 Patients

  • The FDA extended the Emergency Use Authorization (EUA) for Eli Lilly And Co's LLY and Incyte Corporation's INCY rheumatoid arthritis drug Olumiant (baricitinib) to be used as a sole treatment for hospitalized COVID-19 patients who need supplemental oxygen.
  • The oral drug was previously cleared in conjunction with Gilead Sciences Inc GILD remdesivir.
  • In a Phase 3 study reported in April, Olumiant did not meet its primary endpoint. The drug failed to reach statistical significance for the difference in the rate of patients needing non-invasive or invasive ventilation for the first time or those who died after four weeks. 
  • But FDA said that the revised EUA for baricitinib was supported by data from that study, which showed a reduction in the proportion of patients who died after four weeks of follow-up compared to patients treated with the standard of care alone.
  • Price Action: LLY shares are down 0.57% at 245.10, INCY shares are down 0.37% at $77.72 during the market session on the last check Thursday.
  • Related content: Benzinga's Full FDA Calendar.

Posted In: Briefsrheumatoid arthritisBiotechNewsHealth CareFDAGeneral

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.